Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65.
about
Quantitative fundus autofluorescence in healthy eyes.Phospholipid meets all-trans-retinal: the making of RPE bisretinoidsIdentifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.Fundus autofluorescence and the bisretinoids of retina.Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapyThe retinal pigment epithelium in health and diseasePharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration.Interpretations of fundus autofluorescence from studies of the bisretinoids of the retinaC20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease.Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for retinol isomerase.Autofluorescence imaging with near-infrared excitation:normalization by reflectance to reduce signal from choroidal fluorophores.The bisretinoids of retinal pigment epitheliumMutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy.Determination of N-retinylidene-N-retinylethanolamine (A2E) levels in central and peripheral areas of human retinal pigment epitheliumDiseases caused by defects in the visual cycle: retinoids as potential therapeutic agentsHuman retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvementElevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids.Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2The clinical features of retinal disease due to a dominant mutation in RPE65.Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and updateA comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutationA Novel Method for Quantitative Serial Autofluorescence Analysis in Retinitis Pigmentosa Using Image Characteristics.Immuno-histochemical analysis of rod and cone reaction to RPE65 deficiency in the inferior and superior canine retina.Why some photoreceptors die, while others remain dormant: lessons from RPE65 and LRAT associated retinal dystrophies.Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.Prospects for gene therapy of inherited retinal disease.Preserved visual function in retinal dystrophy due to hypomorphic RPE65 mutations.Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.Ultra-widefield fundus autofluorescence patterns in retinitis pigmentosa and other retinal dystrophies.Correlation of ultra-widefield fundus autofluorescence patterns with the underlying genotype in retinal dystrophies and retinitis pigmentosa.
P2860
Q30543909-F3B9AF18-7DCD-4674-8BC6-F4A041E41C6BQ33577803-70162F93-F1DB-4C9F-9C5F-BECE9E6A5CF8Q33771032-8148967A-5C8E-41CE-8FA9-7D790251ED4CQ33809041-AE7261A3-818E-4B25-B412-A8D6FE637230Q33992484-B3EFF603-966A-4433-A107-025D10B3F801Q33998365-D65B8AE8-F27C-4C55-9393-AA3A8D4493E9Q34074393-15A62525-E937-4C55-8911-3E9AA1436725Q34101095-D7D24A13-D000-4909-9F7A-3BF53FD8B560Q34135516-6C0732FD-743D-4AF0-8799-C34BA3BF6FCBQ34624202-E023E693-E047-4201-8E3E-CCD52378D753Q35524221-7D84C6EA-61EA-469E-8DC8-654976807126Q35682509-20306684-34F3-409F-AF92-AE3818703C42Q35785390-BEE5F470-E01C-4852-9B12-77E9790274FEQ36077007-243673C9-71E9-482D-848C-1F59B09EBED3Q36225789-1B33CD0E-9F00-4332-B8BD-36D9E5BEC1E2Q36591612-7130FF5D-6A11-44FE-AB42-0CD844275451Q36598421-A0FD7D00-3D14-4662-B2F8-01D59AE2EBAEQ36738021-12B7FC69-5F1D-4A47-B53D-AE70A2290162Q36906324-6DC7FB34-0727-489B-B007-773D39FFB800Q36989958-F821A701-1F5F-49A9-854A-2E233B89A74AQ36994262-07B76729-42B9-4EC5-A481-66773BA6D046Q37241257-D855B164-1752-4CC1-B59B-B03E7943A598Q37481875-DF7B4753-D59F-450E-8E42-FA29C126C69AQ37500297-77561B74-DCF7-4CF6-AD98-4AD61749058DQ37832477-8736F227-B4F0-4984-A090-8512C6760088Q39423311-2EE2E587-5700-44B2-B6C5-8D8B69DCA9AAQ45882673-B2FD714D-8939-4A79-AF6D-91E2F373A2D8Q46189588-A873D784-C656-4E57-8F29-CF4ED0370297Q47238774-BF5C331A-9E1E-4C07-B1F9-AA8C7E8564DCQ49736427-56800603-CF9A-44EC-9FDC-0F5D1B850F0AQ51307734-3E27259E-BC31-44AA-9583-AE8CCBA9AE49
P2860
Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@ast
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@en
type
label
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@ast
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@en
prefLabel
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@ast
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@en
P2093
P1433
P1476
Lack of fundus autofluorescenc ...... iated with mutations in RPE65.
@en
P2093
Bettina Wabbels
Birgit Lorenz
Christian P Hamel
Erika Wegscheider
Markus N Preising
Wolfgang Drexler
P304
P356
10.1016/J.OPHTHA.2004.01.033
P577
2004-08-01T00:00:00Z